Sodium Salts (NaI/NaBr/NaCl) for the Halogenation of Imidazo-Fused Heterocycles

Article abstract of DOI:10.1021/acs.joc.8b02637

We report herein an effective method for the halogenation of imidazo-fused heterocycles using readily available sodium salts (NaCl/NaBr/NaI) as halogen source and K₂S₂O₈ (or) oxone as promoter. A variety of C-3 halogenated imidazo[1,2-a]pyridines and benzo[d]imidazo[2,1-b]thiazoles were obtained in good to excellent yields. The present method of halogenation has been also extended to 2-aminopyridines, 2-aminopyrimidine, indole, and isoquinoline with moderate to excellent yields.

Full text of DOI:10.1021/acs.joc.8b02637

Subscriber access provided by TULANE UNIVERSITY
Article
Sodium salts (NaI/NaBr/NaCl) for the
halogenation of imidazo-fused heterocycles
Rashmi Semwal, Chitrakar Ravi, Rahul Kumar, Ramavatar Meena, and Subbarayappa Adimurthy
J. Org. Chem., Just Accepted Manuscript • DOI: 10.1021/acs.joc.8b02637 • Publication Date (Web): 18 Dec 2018
Downloaded from http://pubs.acs.org on December 18, 2018
Just Accepted
“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a service to the research community to expedite the dissemination
of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in
full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully
peer reviewed, but should not be considered the official version of record. They are citable by the
Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore,
the “Just Accepted” Web site may not include all articles that will be published in the journal. After
a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web
site and published as an ASAP article. Note that technical editing may introduce minor changes
to the manuscript text and/or graphics which could affect content, and all legal disclaimers and
ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or
consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W.,
Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the course
of their duties.

Page 1 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
Sodium salts (NaI/NaBr/NaCl) for the halogenation of imidazo-
fused heterocycles
7
8
9
Rashmi Semwal, Chitrakar Ravi, Rahul Kumar, Ramavatar Meena and Subbarayappa
Adimurthy*
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Academy of Scientific & Innovative Research, CSIR–Central Salt & Marine Chemicals
Research Institute, G.B. Marg, Bhavnagar-364 002. Gujarat (INDIA).
*E-mail: adimurthy@csmcri.res.in
We report herein an effective method for the halogenation of imidazo-fused heterocycles using
readily available sodium salts (NaCl/NaBr/NaI) as halogen source and K2S2O8 (or) oxone as
promoter. A variety of C-3 halogenated imidazo[1,2-a]pyridines and benzo[d]imidazo[2,1-
b]thiazoles were obtained in good to excellent yields. The present method of halogenation has been
also extended to 2-aminopyridines, 2-aminopyrimidine, indole and isoquinoline with moderate to
excellent yields.
……………………………………………………………………………………………………..
Introduction:
Halogenated (hetero)aromatic compounds are valuable and fundamental building blocks
that are being used to construct carbon–carbon and carbon–heteroatom bonds in organic
synthesis and drug design.1 They play pivotal role in drug and natural-product syntheses.2
Furthermore, (hetero)aromatic bromides and iodides have been extensively used in cross-
coupling3 and in Grignard reactions.4 The functionalization of (hetero) aromatic
compounds with halides through direct activation of C−H bond is a straightforward strategy
to obtain halogenated aromatic products.
In recent years, considerable attention has been paid to the development of new routes for
the construction of halogenated scaffolds, utilising safe and readily available halide sources
such as NH4X, NaX and HX (X= Br, Cl) have been reported.5 Particularly, halogenated
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 2 of 34
1
2
3
4
5
6
7
8
9
imidazofused heterocycles represent an important class of molecules and show unique
bioactivities. Particularly, functionalised imidazo[1,2-a]pyridines through halogenations
were commercially marketed as drugs. For example, C-3 substituted imidazo[1,2-
a]pyridines are well known drug candidates such as zolimidine (pepticulcer), alpidem
(anxiolytic), zolpidem (insomnia), saripidem (anxiolytic), olprinone (cardiotonic),
necopidem, minodronic acid (antiosteoporosis) and GSK812397 (anti HIV) are basic
imidazo[l,2-a]pyridine skeleton are clinically derived (Figure 1).6
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Figure 1. Biological activity of imidazo[1, 2–a]pyridines
In recognition of the importance of these molecules, recently many research groups
demonstrated the halogenation of imidazo[1,2-a]pyridines using CuX, NXS and X2 (X=Br,
‑
I) for bromination and iodination,7,8 NCS and Chloramine T for chlorination (Scheme 1).9
Recently, sodium chlorite/bromite has been reported as a halogen source.10 Even though
these methods are efficient, there were no reports for the halogenation of imidazo[1,2-
a]pyridines with simple sodium salts as halogenation source. In continuation
Scheme 1. Halogenation of 2-phenylimidazo[1,2-a]pyridine
ACS Paragon Plus Environment

Page 3 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
of our efforts on the functionalization of imidazo[1,2-a]pyridines,11 and development of
eco-friendly halogenation reagents,12 we report herein the halogenation of imidazo[1,2-
a]pyridines and representative other heterocycles using readily available sodium salts (NaI,
NaBr and NaCl) as a source for the halogenation under mild reaction conditions.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Results and Discussion:
Initially, we focused on the optimization of conditions for the iodination of 2-phenylimidazo[1,2-
a]pyridine 1a using sodium iodide (NaI; 2a) as iodine source with Na2S2O8 as oxidant at 60°C in
dichloroethane (DCE) as solvent. To our delight, the desired product 3-iodo 2-phenylimidazo[1,2-
a]pyridine 3a was isolated in 54% yield after 24 h of reaction time (Table 1, entry 1). When the
reaction was performed with K2S2O8 as oxidant instead of Na2S2O8, it resulted in 61% yield of the
product 3a (Table 1, entry 2). The same reaction in acetonitrile (ACN) as solvent the yield of 3a
was increased to 66% (entry 3). To enhance the yield of the iodination, the amount of both NaI
and K2S2O8 were increased to 0.5 equivalents under these conditions the product yield was raised
to 74% (entries 4 and 5).
By decreasing the temperature from 60 to 50°C, the yield of 3a was increased to 82%, it
may be due to the stabilisation of the reactive species generated in-situ (entry 6). Further
conducting the reaction at room temperature the yield was decreased to 76% (entry 7). It
was observed that, temperature of the reaction was another decisive factor which influence
the yield of the product (Table 1, entries 6 & 7). Then, we checked the reaction in
dichloromethane (DCM) and diethyl ether (DEE) as solvents, in these cases 75% yield of
3a and no reaction was observed respectively (Table 1, entries 8 and 9). To check the effect
of iodide salt, the reaction was performed with ammonium iodide (NH4I; 0.5 mmol) in
place of NaI, at 50
℃ , under these conditions the yield of desired product was decreased to
60% (entry 10). Based on above studies we fixed the table 1, entry 6 as the best suitable
conditions for the extension of iodination for other substrates. Encouraged by the above
results on iodination of 1a, our studies further applied towards optimization of reaction
conditions for bromination and chlorination using NaBr (2b) and NaCl (2c) as
corresponding halogen sources.
With the optimized conditions of iodination (entry 6), 1a was subjected to bromination
using NaBr as bromine source. Interestingly, 44% of brominated product 4a was obtained
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 4 of 34
1
2
3
4
5
6
7
8
9
(Table 1, entry 11). When the reaction was conducted at room temperature (entry 12) and
in DCM as solvent (entry 13) the yield of the bromo product 4a was marginally increased
(53% and 54%). With DCM as solvent, the NaBr amount was increased to 1.0 - 1.25 mmol,
the yield of 4a was obtained in 84% and 95% respectively (entries 14 and 15).
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Table 1. Screening of conditions for halogenation of 1aa
ACS Paragon Plus Environment

Page 5 of 34
The Journal of Organic Chemistry
1
2
3
aReaction conditions: 1a (0.25 mmol), 2, oxidant, solvent (1.0 mL), 24 h, isolated yields. For entries 26-31 the 2:1 ratio of
4
5
mixture of solvents. DCE (dichloroethane), DCM (dichloromethane), ACN (acetonitrile), DEE (diethyl ether)
6
7
8
9
Interestingly, the reaction works moderately with acetone as solvent (entry 16). Also, we
performed the reaction with NH4Br as a brominating reagent, but the yield was reduced to
50% (entry 17). We then, extended the methodology for the chlorination of 1a under the
same conditions using NaCl (2c) as chlorine source (entry 18). By screening the various
conditions such as solvent, temperature and oxidant, the desired product 3-chloro-2-
phenylimidazo[1,2-a]pyridine 5a was obtained up to 60% yield (Table 1, entries 18-25).
Further we screened the reaction with, aqueous mixture of solvents, ammonium chloride
NH4Cl and varying the amount of oxidant (oxone) at 80°C (entries 26-31), the best yield of
chlorinated product was obtained under the conditions of; 1.25 mmol of NaCl, 0.5 mmol
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
of oxone, 2:1 mixture of acetonitrile and water (ACN+H2O) as solvent at 80
entry 26).
℃ (Table 1,
With the above optimised conditions, we explored the substrate scope for the halogenation
(I/Br/Cl) of different imidazopyridines (Table 2). First, we examined the C-3 iodination of para
substituted 2-phenylimidazo[1,2-a]pyridines using NaI as iodine source (with the conditions of
Table 1, entry 6). To our delight, the protocol tolerated the presence of electron-rich and electron-
deficient groups (i.e., Et, F, and CN) and proceeded smoothly under the optimized conditions to
give good yields (60–84 %) of selectively C-3 iodinated products 3b–3d. The presence of electron-
rich and electron-deficient groups (i.e., Me, Et, OMe, Cl, Br, and CN) at different positions of the
phenyl as well as pyridyl ring of the 2-phenylimidazo[1,2-a]pyridines were underwent to these
conditions smoothly to afford the corresponding C-3 iodinated imidazo-[1,2-a]pyridines 3e–3l in
low to good yields (37–94 %). Dichloro, halo and alkyl substituted imidazopyridines also gave the
corresponding iodinated products 3m–3p in moderate yields. The iodination of unsubstituted
imidazo(1,2-a)pyridine offered 45% yield of selective C-3 mono-iodinated product 3q.
Table 2. Scope of halogenation of imidazo[1,2-a]pyridines a,b,c
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 6 of 34
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Reaction conditions for products (3a-q) a: 1 (0.25 mmol), 2a (0.5 mmol, 2.0 equiv.), K2S2O8 (0.5
mmol, 2.0 equiv.), ACN (1 mL), 50°C, 24 h. For (4a-p) b: 1 (0.25 mmol), 2b (1.25 mmol, 5.0
equiv.), K2S2O8 (0.5 mmol, 2.0 equiv.), DCM (1 mL), RT, 24 h. For (5a-b)c: 1 (0.25 mmol), 2c
ACS Paragon Plus Environment

Page 7 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
7
(1.25 mmol, 5.0 equiv.), oxone (0.5 mmol, 2.0 equiv.), [ACN+ H2O] (1 ml), 80°C, 24 h. d Gram
scale synthesis (all reaction are performed at 6.0 mmol w.r.t. 1). All the reported products are
isolated yields after column chromatographic separation.
8
9
Then we focused on the bromination of substituted 2-phenylimidazo[1,2-a]pyridines (with
the conditions of Table 1, entry 15). Similar to iodination, the bromination also underwent
smoothly with electron-rich and electron-deficient groups (i.e., Me, Et, OMe, Cl, Br, F and
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
CN) at different positions of the phenyl as well as pyridyl ring of
corresponding C-3 brominated products 4b 4l in good to excellent yields (62–96%). Even
dichloro, halo, alkyl substituted and unsubstituted imidazopyridines gave the corresponding
1, and afford the
–
brominated products 4m-4p in moderate to good yields respectively under the same
conditions.
Two
representative
imidazopyridines,
2-phenylimidazo[1,2-a]pyridine
and
4-(8-
methylimidazo[1,2-a]pyridin-2-yl)benzonitrile were also subjected to chlorination (under the
conditions of table 1, entry 26) and obtained moderate to good yields of C-3 chlorinated products
5a and 5b. Compared to iodination and bromination, fewer yields of corresponding chlorination
products were observed. The unsubstituted imidazo(1,2-a)pyridine was subjected to chlorination
but, corresponding chlorinated product was not observed. It may be due to the low reactivity of
chlorine species under the present conditions. It may be noted that, the poly halogenated
imidazopyridine derivatives 3m, 3n, 4m and 4n were well tolerated, and these products could be
further useful in traditional cross-coupling reactions. To validate the present protocol for
industrial/commercial preparation of such products, the halogenation (I, Br, and Cl) of 1a was
carried out at gram scale using 2a, 2b and 2c under the optimised conditions and obtained the
corresponding halogenated 2-phenyl imidazopyridines i.e. 3a, 4a, 5a in moderate to good yields
(See Table 2, footnotes).
To further ascertain the scope of the present halogenation method, different fused
heterocycles such as 6-phenylimidazo[2,1-b]thiazole13 and 2-phenylbenzo[d]imidazo[2,1-
b]thiazole were studied with the optimised conditions of table 2, and results are presented
in Table 3. Initially, the iodination of 6-phenylimidazo[2,1-b]thiazole
6 having various
substituents (Me, OMe, Et, Br, Cl and F) at the phenyl ring, was subjected to the iodination
and obtained the corresponding 5-iodo-6-phenylimidazo[2,1-b]thiazole derivatives (7a–7e)
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 8 of 34
1
2
3
4
5
6
7
8
9
in moderate to good yields. Further, the iodination of 2-phenylbenzo[d]imidazo[2,1-
b]thiazoles offered the corresponding 3-iodo-2-phenylbenzo[d]imidazo[2,1-b]thiazole
derivatives (7f
phenylimidazo[2,1-b]thiazole and 2-phenylbenzo[d]imidazo[2,1-b]thiazole derivatives
provided the corresponding bromo products 8a 8h in 56-89% yields. As observed in Table
2, fewer yields of chloro derivatives 9a 9c were observed (Table 3). The halogenation of
indole under the present conditions, didn’t proceed to yield the desired products (9d 9f).
–7h) in moderate yields (50-63%). Similarly, the bromination of 6-
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
–
–
-
However, bromination of N-pivaloyl indole under the optimised conditions gave the desired
product 9g in quantitative yield (99%). The product 9g was obtained in pure form by NMR,
without separation by column chromatography, but by solvent extraction and removal of
solvent. It may be noted that, indole derivatives are promising scaffolds for drug
development.14 Interestingly, 3-bromoisoquinoline 9h was also obtained in 40% yield.
Unfortunately, benzothiazole and benzofuran completely declined to yield the halogenated
products (9i–9n).
Table 3. Halogenation of other fused heterocyclesa,b,c
ACS Paragon Plus Environment

Page 9 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
aReaction conditions for product (7a-h): 6 (0.25 mmol), 2a (0.5 mmol, 2.0 eqv.), K2S2O8 (0.5
mmol, 2.0 eqv.), ACN (1 mL), 50°C, 24 h. bFor (8a-h & 9g-h): 6 (0.25 mmol), 2b (1.25 mmol,
5.0 eqv.), K2S2O8 (0.5 mmol, 2.0 eqv.), DCM (1 mL), RT, 24 h. c For (9a-c): 6 (0.25 mmol), 2c
(1.25 mmol, 5.0 eqv.), oxone (0.5 mmol, 2.0 eqv.), ACN+ H2O (2:1, 1 mL), 80°C, 24 h. All
yields of products are isolated except 9g.
Finally for our curiosity, we applied the same optimised conditions for the iodination and
bromination of 2-aminopyridine 10a, and obtained 5-iodo-2-aminopyridine 11a and 5-bromo-2-
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 10 of 34
1
2
3
4
5
6
7
8
9
aminopyridine 11b in 47% and 58% yields respectively (Scheme 2). Halogenation of 2- and 3-
aminopyridines did not undergo under the present conditions. Further the chlorination of biological
active compound such as pyrimidine15 10b gave desired product 5-chloro-4, 6-dimethylpyrimidin-
2-amine 11c in 51% isolated yield (Scheme 2).
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Scheme 2. Halogenation of aminopyridine and aminopyrimidine
To explore the importance of these halogenated fused heterocycles, we further subjected to the
cross coupling reactions for making C-C bonds under the conditions of known procedure.
Compounds 3a and 4a reactions with benzene and phenylboronic acid with palladium catalytic
conditions afford the desired product 2, 3-diphenylimidazo[1,2-a]pyridine 12a in 60% and 65%
respectively (Scheme 3). The cross coupled product 12a, displays significance biological activity
towards anti-apoptotic, antiprotozoal, and antiviral activities, and also shows significance
reactivity towards kinase inhibitors as well as liver X receptor agonists (Scheme 3). 16
Scheme 3. Applications of halogenated heterocycles for cross coupling reactions.
ACS Paragon Plus Environment

Page 11 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
To gain insight into the reaction mechanism, specific control experiments were performed
(Scheme 4). We subjected the reaction of 1a with halogenations (iodo, bromo and chloro)
reactions under the optimised conditions by the addition of radical scavenger (2,2,6,6-
tetramethylpiperidin- 1-yl)oxyl (TEMPO), under these conditions the desired halogenated
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
products 3a, 4a and 5a were observed in 20%, 13% and 62% yields respectively (Scheme
4, eq. a-c). In addition to the desired products, the ring opening product N-(pyridin-2-
yl)benzamide 13 was observed in 59%, 67% and 30% yield respectively (Scheme 4, eq. a-
c). The product 13 formation is known in the literature under strong oxidising conditions.
17f
Along with the above products, the TEMPO adduct 14 was detected by HRMS in the
case of iodination but no such adduct was observed for bromination and chlorination
(Scheme 4, eq. a-c).18
Scheme 4. Control experiments (a GC-MS yield)
In order to conclude the reactive species for the present transformation, we performed the
bromination of 1a under the optimised conditions along with NaOH (Scheme 4, eq. d).
Interestingly, only traces of 4a formation was observed. It indicates that, the Br2 may
generate in-situ and which will be trapped by NaOH. From the equations b-d, (Scheme 4),
it concludes the bromination may follow ionic pathway (Scheme 4, eq. d).
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 12 of 34
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Scheme 5. Plausible reaction mechanism
Based on mixed results from the above control experiments and based on the literature
reports17 two plausible reaction paths have been proposed (Scheme 5). The iodination may
proceed via both ionic and radical pathways, but the bromination and chlorination may
follow ionic pathways (Scheme 5). In path a; initially, K2S2O8 thermally decomposes into
sulphate radical (SO4−•)17d,e which in turn reacts with NaI to generate iodine radical (I•).
Addition of iodine radical (I•) to the C3 position of 1a generates radical intermediate
Subsequently, single electron transfer (SET) and oxidative aromatisation may deliver the
desired product 3a through the intermediate (Scheme 5, path a). In path b; the molecular
A.
B
halogen generated in-situ by the oxidant may attack electrophilically (x+) on the C3
position of 1a to generate another imidazolonium intermediate C.11d&17 Followed by
elimination of HX from C, gives the desired halogenated products (Scheme 5, path b).
In summary, the present study is an attractive alternative to the previously reported
halogenation techniques. The use of simple sodium halide salts (NaI/NaBr/NaCl) for the
halogenation are being reported first time in the present study. The present transformation
indicates very good functional group tolerance and broad substrate scope of imidazo[1,2-
a]pyridines and applicable at gram scale synthesis of desired halogenated compounds. The
ACS Paragon Plus Environment

Page 13 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
method is also applicable for the synthesis of important heterocyclic compounds such as
imidazo[2,1-b]thiazoles and benzo[d]imidazo[2,1-b]thiazoles as well as indole,
isoquinoline, pyrimidine and 2-aminopyridines with moderate to good yields. Due to the
less reactivity of chloride, yields for chlorination are not much excited, nevertheless it
represents a significant development for the chlorination of imidazoheterocycles using
table salt as chlorine source.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Experimental Section:
General: All commercially available chemicals and reagents were used without any further
1
13
purification unless otherwise indicated. H and C{H} NMR spectra were recorded at 600, and
150 MHz, respectively. The spectra were recorded in CDCl3 as solvent. Multiplicity was indicated
as follows: s (singlet); d (doublet); t (triplet); m (multiplet); dd (doublet of doublets), etc. and
coupling constants (J) were given in Hz. Chemical shifts are reported in ppm relative to TMS as
1
13
an internal standard. The peaks around delta values of H NMR (7.26), and C{H}NMR (77.0)
are deuterated solvent chloroform, [δ value around (1.5) in 1H NMR is of water]. Mass spectra
were obtained using electron impact (EI) ionization method. Progress of the reactions was
monitored by thin layer chromatography (TLC). All products were purified through column
chromatography using silica gel 100-200 mesh size using hexane/ethyl acetate as eluent, unless
otherwise indicated.
General procedure for the synthesis of 2-phenylimidazo[1,2-a]pyridine (1):
470 mg (5.0 mmol) of 2-aminopyridine, 1200 mg (10 mmol) of acetophenone, CuI 5 mol% (47
mg; 0.25 mmol), BF3·Et2O (45–50% purity); 10 mol%, (0.5 mmol) and DMF (2 mL) were placed
in a 25-mL double-necked round-bottomed flask. The mixture was heated in oil bath at 60 oC for
24 h under an oxygen atmosphere (balloon). After completion of the reaction, it was allowed to
attain to room temperature and then the mixture was poured into 20 mL of sodium carbonate
solution. The product was extracted with DCM (50 mL X 3) and dried with anhydrous Na2SO4.
Removal of the solvent under reduced pressure and the leftover residue was purified through
column chromatography using silica gel (30% EtOAc/hexane) to afford 1a; yield: 0.799 g (82%)
experimental data also matched with reported literature the same method was applied for all the
reported starting substrates (1,6 and their derivatives).13
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 14 of 34
1
2
3
4
5
6
7
8
9
General procedure for the synthesis of 3-iodo-2-phenylimidazo[1,2-a]pyridine (3a): To a
reaction tube equipped with a magnetic stir bar, added 2-phenylimidazo[1,2-a]pyridine13 (1a) (48.5
mg, 0.25 mmol), sodium iodide (2a) (75mg, 0.5 mmol), and potassium persulfate (135 mg, 0.5
mmol) and 1.0 mL of acetonitrile (ACN). The mixture was heated in an oil bath at 50 ⁰ C in a
closed tube. Reaction was monitored by TLC, after completion of the reaction; it was allowed to
attain room temperature. Then the mixture was poured into 30 mL of sodium thiosulfate solution
and the product was extracted with EtOAc. The combined organic layers were dried over
anhydrous Na2SO4 and solvent was removed under vacuum. The crude residue leftover was
purified by column chromatography using 15 % EtOAc/hexane to afford 3a (65.6 mg; 82% yield).
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
General procedure for the synthesis of 3-bromo-2-(4-ethylphenyl)benzo[d]imidazo[2,1-
b]thiazole (8f): To a reaction tube equipped with a magnetic stir bar, added 2-(4-
ethylphenyl)benzo[d]imidazo[2,1-b]thiazole (6)13 (69.5 mg, 0.25 mmol), sodium bromide (2b)
(127 mg, 1.25 mmol), and potassium persulfate (135 mg, 0.5 mmol) and 1.0 mL of
dichloromethane (DCM). The mixture was stirred at room temperature in a closed tube. Reaction
was monitored by TLC. The product was extracted with EtOAc and the combined organic layers
were dried over Na2SO4, concentrated under vacuum. The crude mixture was purified by silica gel
column chromatography using 15 % EtOAc/hexane to afford 4a (68.53 mg; 77% yield).
General procedure for the synthesis of 3-chloro-2-phenylimidazo[1,2-a]pyridine (5a): To a
reaction tube equipped with a magnetic stir bar, added 2-phenylimidazo[1,2-a]pyridine (1a) (48.5
mg, 0.25 mmol), sodium chloride (2c) (72.5mg, 1.25 mmol), and potassium peroxymonosulfate
(114 mg, 0.5 mmol) and 1.0 mL of ACN+ H2O (2:1). The mixture was heated in an oil bath at 80
⁰ C in a closed tube. Reaction was monitored by TLC. The product was extracted with EtOAc and
the combined organic layers were dried over anhydrous Na2SO4, the solvent was removed under
vacuum. The crude residue leftover was purified by silica gel column chromatography using 15 %
EtOAc/hexane to afford 5a (37.05 mg; 65% yield).
Characterization data :
ACS Paragon Plus Environment

Page 15 of 34
The Journal of Organic Chemistry
1
2
3
4
3-iodo-2-phenylimidazo[1,2-a]pyridine (3a): 25a
5
6
7
8
(Eluent: 15% EtOAc/hexane); 82% yield (65.6 mg); yellow solid, Mp: 165 0C ; 1H
NMR (600 MHz, CDCl3) δ 8.19 (d, J = 6.9 Hz, 1H), 8.06 (d, J = 7.9 Hz, 2H), 7.61
(d, J = 9.1 Hz, 1H), 7.48 (t, J = 7.8 Hz, 2H), 7.39 (t, J = 7.1 Hz, 1H), 7.24 – 7.19
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
13
(m, 1H), 6.88 (t, J = 6.8 Hz, 1H); C{H} NMR (150 MHz, CDCl3) δ 147.999,
147.904,133.45, 128.43, 128.27,128.26, 126.42, 125.49, 117.46, 113.08 , 59.50.
2-(4-ethylphenyl)-3-iodoimidazo[1,2-a]pyridine (3b):
0
(Eluent: 20% EtOAc/hexane); 68% yield (59.1 mg); yellow solid; Mp: 190 C;
1H NMR (600 MHz,CDCl3) δ 8.22 (d, J = 6.9 Hz, 1H), 8.00 (d, J = 8.0 Hz, 2H),
7.61 (d, J = 9.1 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.25 (dd, J = 9.2, 7.2 Hz, 1H),
6.92 (d, J = 6.8 Hz, 1H), 2.72 (d, J = 7.4 Hz, 2H), 1.29 (t, J = 7.5 Hz, 3H); 13C{H}
NMR (150 MHz, CDCl3) δ 148.11, 148.06, 144.49, 130.86, 128.41, 127.85,
126.45, 125.41, 117.49, 113.03, 77.00, 59.10, 28.68, 15.41. HRMS-ESI (m/z) [M+Na]+ calcd. For
C15H13IN2Na: 371.0021; Found: 371.0019.
2-(4-fluorophenyl)-3-iodoimidazo[1,2-a]pyridine (3c):
(Eluent: 15% EtOAc/hexane); 84% yield (70.9 mg); yellow solid, Mp: 152 0C; 1H
NMR (600 MHz, CDCl3) δ 8.23(d, J= 7.2 Hz, 1H), 8.05-8.03(m, 2H), 7.61(d, J=
8.4 Hz, 1H), 7.27 (t, J= 9.0 Hz, 1H), 7.18 (t, J= 8.4 Hz, 2H), 6.95 (t, J= 6.6 Hz, 1H);
13C{H} NMR (150 MHz, CDCl3 ) δ 163.69, 162.04, 148., 147.29, 130.29 (d, J =
8.4 Hz), 129.71, 126.53, 125.69, 117.57, 115.42, 115.28, 113.26, 59.20; HRMS-
ESI (m/z) [M+H]+calcd. For C13H9FIN2: 338.9794; Found: 338.9799.
4-(3-iodoimidazo[1,2-a]pyridin-2-yl)benzonitrile (3d): 26a
(Eluent: 20% EtOAc/hexane); 60% yield (51.7 mg); white solid, Mp: 120 0C; 1H
NMR (600 MHz, CDCl3) δ 8.23 (d, J= 8.4 Hz, 3H), 7.75 (d, J= 7.8 Hz, 2H), 7.62
(d, J= 9.0 Hz, 1H), 7.31 (t, J= 7.8 Hz, 1H), 6.98 (t, J= 6.6 Hz, 1H); 13C{H} NMR
(150 MHz, CDCl3) δ 148.4, 145.8, 138.2, 132.2, 128.8, 126.7,126.3,117.9, 113.8,
60.6.
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 16 of 34
1
2
3
4
5
6
7
8
9
2-(4-ethylphenyl)-3-iodo-6-methylimidazo[1,2-a]pyridine (3e):
(Eluent: 20% EtOAc/hexane); 94% yield (85.0 mg); white solid, Mp:130 0C;
1H NMR (600 MHz, CDCl3 ) δ 8.00 – 7.94 (m, 3H), 7.50 (d, J = 9.0 Hz, 1H),
7.30 (d, J = 8.1 Hz, 2H), 7.09 (s, 1H), 2.70 (d, J = 7.8 Hz, 2H), 2.39 (s, 3H),
1.30 – 1.25 (m, 3H); 13C{H} NMR (150 MHz, CDCl3 ) δ 147.85, 147.14,
144.34, 131.06, 128.51, 128.35, 127.81, 124.22, 122.81, 116.85, 77.00, 58.58,
28.69, 18.35, 15.41. HRMS-ESI (m/z) [M+Na]+calcd. For C16H15IN2Na: 385.0178; Found:
385.0179.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
3-iodo-2-(4-methoxyphenyl)-6-methylimidazo[1,2-a]pyridine (3f):
(Eluent: 20% EtOAc/hexane); 37% yield (33.6 mg); yellow solid, Mp:190 0C;
1H NMR (600 MHz, CDCl3 ) δ 8.02 – 7.93 (m, 3H), 7.48 (d, J = 9.1 Hz, 1H),
7.07 (d, J = 9.0 Hz, 1H), 6.99 (d, J = 8.3 Hz, 2H), 3.85 (s, 3H), 2.38 (s, 3H);
13C{H} NMR (150 MHz, CDCl3 ) δ 159.62, 147.60, 147.06, 129.66, 128.47,
126.22, 124.16, 122.74, 116.67, 113.71, 77.00, 58.19, 55.26, 18.31. HRMS-
ESI (m/z) [M+H]+calcd. For C15H14IN2O: 365.0151; Found: 365.0160.
2-(4-chlorophenyl)-3-iodo-6-methylimidazo[1,2-a]pyridine (3g):
0
(Eluent: 15% EtOAc/hexane); 79% yield (72.6 mg); yellow solid, Mp:170 C;
1H NMR (600 MHz, CDCl3) δ8.01 (d, J= 8.4 Hz, 2H), 7.97 (s, 1H), 7.50 (d, J=
9.0 Hz, 1H), 7.44 (d, J= 8.4 Hz, 2H), 7.11 (d, J= 9.6 Hz, 1H), 2.39 (s, 3H);
13C{H} NMR (150 MHz, CDCl3) δ 147.1, 146.5, 134.0, 132.2, 129.6, 128.9,
128.5, 124.2, 123.1, 116.9, 59.9, 18.3. HRMS-ESI (m/z) [M+H]+calcd. For
C14H11ClIN2: 368.9655; Found: 368.9657.
4-(3-iodo-6-methylimidazo[1,2-a]pyridin-2-yl)benzonitrile (3h):
(Eluent:20% EtOAc/hexane); 50% yield (44.87 mg); yellow solid, Mp: 200 0C;
1H NMR (600 MHz, CDCl3 ) δ 8.22 (d, J = 8.9 Hz, 2H), 8.00 (s, 1H), 7.74 (d, J
= 8.4 Hz, 2H), 7.52 (d, J = 9.1 Hz, 1H), 7.15 (d, J = 9.2 Hz, 1H), 2.42 (s, 3H);
13C{H} NMR (150 MHz, CDCl3) δ 147.36, 145.46, 138.31, 132.11, 129.46,
128.67, 124.31, 123.66, 118.94, 117.17, 111.46, 77.00, 59.94, 18.38. HRMS-
ESI (m/z) [M+H]+calcd. For C15H11IN3: 359.9998; Found: 359.9987.
ACS Paragon Plus Environment

Page 17 of 34
The Journal of Organic Chemistry
1
2
3
4
4-(3-iodo-8-methylimidazo[1,2-a]pyridin-2-yl)benzonitrile (3i):
5
6
Eluent: 10% EtOAc/hexane); 60% yield (53.8 mg); yellow solid, Mp: 190 0C; 1H
7
8
9
NMR (600 MHz, CDCl3) δ 8.23 (d, J= 7.8 Hz, 2H), 8.09 (d, J= 6.6 Hz, 1H), 7.75
(d, J= 8.4 Hz, 2H), 7.09 (d, J= 6.6 Hz, 1H), 6.88 (t, J= 7.2 Hz, 1H), 2.65 (s, 3H);
13C{H} NMR (150 MHz, CDCl3) δ 148.6, 145.2, 138.4, 132.0, 128.8, 127.9,
124.8, 124.4, 118.9, 113.5, 111.3, 60.7, 56.9, 16.4. HRMS-ESI (m/z) [M+H]+
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
calcd. For C15H11IN3: 359.9998; Found: 359.9993.
2-(4-chlorophenyl)-3-iodo-7-methoxyimidazo[1,2-a]pyridine (3j):
(Eluent: 10% EtOAc/hexane); 68% yield (65.2 mg); yellow solid, Mp:190 0C ;1H
NMR (600 MHz, CDCl3 ) δ 8.00 (dd, J = 7.6, 5.5 Hz, 3H), 7.42 (d, J = 8.6 Hz,
2H), 6.89 (d, J = 2.0 Hz, 1H), 6.63 (dd, J = 7.0, 2.1 Hz, 1H), 3.87 (s, 3H); 13C{H}
NMR (150 MHz, CDCl3 ) δ 158.82, 149.18, 146.60, 134.00, 132.18, 129.37,
128.50, 126.80, 108.26, 94.80,56.67, 55.70. HRMS-ESI (m/z) [M+H]+calcd. For
C14H11ClIN2O: 384.9605; Found: 384.9604.
7-chloro-3-iodo-2-phenylimidazo[1,2-a]pyridine (3k):
(Eluent: 20% EtOAc/hexane); 62% yield (54.8 mg); yellow solid, Mp: 150 0C ;
1H NMR (600 MHz, CDCl3) δ 8.15 (d, J= 7.8,1H), 8.04 (d, J= 7.2 Hz, 2H), 7.63
(s, 1H), 7.49 (t, J= 7.2 Hz, 2H), 7.42 (t, J= 7.2 Hz, 1H), 6.91 (t, J= 1.8 Hz, 1H);
13C{H} NMR (150 MHz, CDCl3) δ 149.0, 147.5, 128.5, 128.42, 128.41, 126.7,
117.2, 114.7, 59.5. HRMS-ESI (m/z) [M+H]+calcd. For C13H9ClIN2: 354.9499;
Found: 354.9491.
6-bromo-3-iodo-2-phenylimidazo[1,2-a]pyridine (3l): 26a
(Eluent: 10% EtOAc/hexane); 91% yield (90.7 mg);yellow solid, Mp: 178 0C; 1H
NMR (600 MHz, CDCl3) δ 8.36 (s, 1H), 8.04 (d, J= 6.6 Hz, 2H), 7.51-7.47 (m,
13
3H), 7.42 (t, J= 7.8 Hz, 1H), 7.31 (t, J= 9.0 Hz, 1H); C{H} NMR (150 MHz,
CDCl3) δ 148.8, 146.6, 133.0, 129.0, 128.5, 128.45, 128.40, 126.7, 118.1, 108.0,
59.8.
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 18 of 34
1
2
3
4
7-chloro-2-(4-chlorophenyl)-3-iodoimidazo[1,2-a]pyridine (3m):
5
6
7
8
(Eluent: 20% EtOAc/hexane); 60% yield (58.3 mg);white solid, Mp: 175 0C; 1H NMR
(600 MHz, CDCl3) δ 8.15 (d, J= 7.2 Hz, 1H), 8.00 (d, J= 9.0 Hz, 2H), 7.62 (s, 1H),
7.46 (d, J = 9.0 Hz, 2H), 6.93 (t, J = 6.6 Hz, 1H); 13C{H} NMR (150 MHz, CDCl3) δ
147.9, 147.6, 134.6, 132.3, 131., 129.6, 128.6, 126.78, 116.3, 114.9, 59.5, 29.6 HRMS-
ESI (m/z) [M+H]+calcd. For C13H8Cl2IN2: 388.9109; Found: 388.9108.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
6-chloro-2-(4-chlorophenyl)-3-iodoimidazo[1,2-a]pyridine (3n):
(Eluent: 10% EtOAc/hexane); 60% yield (58.3 mg); yellow solid, 190 0C; 1H
NMR (600 MHz, CDCl3) δ 8.26 (s,1H), 7.99 (d, J= 8.4 Hz, 2H), 7.55 (d, J= 9.6
Hz, 1H), 7.45 (d, J= 9.0 Hz, 2H), 7.24-7.23 (m, 1H); 13C{H} NMR (150 MHz,
CDCl3) δ 147.8, 146.5, 134.6, 131.6, 129.6, 128.6, 127.2, 124.5, 121.7, 117.9,
60.0. HRMS-ESI (m/z) [M+H]+calcd. For C13H8ICl2N2:388.9109; Found:
388.9094.
6-fluoro-3-iodo-2-(p-tolyl)imidazo[1,2-a]pyridine (3o):
(Eluent: 15% EtOAc/hexane); 58% yield (51.0 mg); yellow solid, Mp: 160 0C;
1H NMR (600 MHz, CDCl3) δ 8.21 – 8.16 (m, 1H), 7.93 (d, J = 8.0 Hz, 2H),
7.60 (dd, J = 9.6, 5.0 Hz, 1H), 7.29 (d, J = 7.9 Hz, 2H), 7.17 (ddd, J = 10.2, 8.0,
2.2 Hz, 1H), 2.42 (s, 3H); 13C{H} NMR (150 MHz, CDCl3 ) δ 154.59, 153.01,
149.46, 145.71, 138.43, 130.39, 129.12, 128.25, 117.99 (d, J = 8.9 Hz), 117.42,
117.26, 113.70, 113.42, 21.33. HRMS-ESI (m/z) [M+Na]+calcd. For
C14H10FIN2Na: 374.9770; Found: 374.977.
6-bromo-2-(4-ethylphenyl)-3-iodoimidazo[1,2-a]pyridine (3p):
ACS Paragon Plus Environment

Page 19 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
7
(Eluent: 5% EtOAc/hexane); 60% yield (64.0 mg); yellow solid, Mp: 156 0C;
1H NMR (600 MHz, CDCl3) δ 8.36 (s, 1H), 7.97 (d, J = 8.0 Hz, 2H), 7.51 (d,
J = 9.3 Hz, 1H), 7.31 (t, J = 8.7 Hz, 3H), 2.72 (q, J = 7.6 Hz, 2H), 1.29 (t, J =
8
9
13
7.8 Hz, 3H); C{H} NMR (150 MHz, CDCl3) δ 148.89, 146.56, 144.83,
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
130.38, 128.89, 128.37, 127.93, 127.79, 126.66, 118.06, 107.88, 77.00, 59.48,
36.93, 28.70, 27.94, 15.39, 13.99. HRMS-ESI (m/z) [M+H]+calcd. For
C15H13BrIN2: 426.9307. Found: 426.9316.
3-iodoimidazo[1,2-a]pyridine (3q): 24
0
1
(Eluent: 30% EtOAc/hexane); 45% yield (55.0 mg); Brown solid, Mp: 165 C; H
NMR (600 MHz, CDCl3) δ 8.05 (d, J = 6.8 Hz, 2H), 7.58 (d, J = 4.5 Hz, 3H), 7.56 (s,
2H), 7.20 – 7.14 (m, 2H), 6.87 (t, J = 6.8 Hz, 2H). 13C{H} NMR (150 MHz, CDCl3) δ
145.83, 133.60, 124.33, 123.60, 117.88, 112.97, 94.71.
3-bromo-2phenylimidazo[1,2-a]pyridine (4a): 8b
(Eluent: 15%EtOAc/hexane); 95 % yield (64.8 mg); yellow solid, Mp: 85 0C;
1H NMR (600 MHz, CDCl3 ) δ 8.02 (dd, J = 13.8, 7.4 Hz, 3H), 7.56 (d, J = 9.0
Hz, 1H), 7.36 (t, J = 7.7 Hz, 2H), 7.27 (t, J = 7.2 Hz, 1H), 7.18 – 7.10 (m, 1H),
6.80 (t, J = 6.6 Hz, 1H); 13C{H} NMR (150 MHz, CDCl3) δ 145.14, 142.22,
132.41, 128.38, 127.82, 125.36, 123.90, 117.37, 113.18, 91.7.
3-bromo-2-(4-ethylphenyl)imidazo[1,2-a]pyridine (4b): 28a
(Eluent: 15% EtOAc/hexane); 62% yield (46.6 mg);white solid, Mp:105 0C ; 1H
NMR (600 MHz, CDCl3 ) δ 8.16 (d, J = 6.9 Hz, 1H), 8.05 (d, J = 8.5 Hz, 2H),
7.63 (d, J = 8.9 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.25 – 7.22 (m, 1H), 6.92 (d,
J = 6.8 Hz, 1H), 2.71 (d, J = 7.7 Hz, 2H), 1.28 (t, J = 7.6 Hz, 3H); 13C{H} NMR
(150 MHz, CDCl3) δ 145.37, 144.47, 142.75, 130.19, 127.96, 127.79, 124.92,
123.87, 117.50, 112.89, 91.35, 77.00, 28.68, 15.41.
3-bromo-2-(4-fluorophenyl)imidazo[1,2-a]pyridine (4c): 8b
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 20 of 34
1
2
3
4
5
6
7
8
9
0
(Eluent: 5% EtOAc/hexane); 62% yield (45.1 mg); white solid, Mp: 110 C; 1H
NMR (600 MHz, CDCl3) δ 8.13-8.12 (m, 3H), 7.63 (d, J= 6.0 Hz, 1H), 7.26-7.17
(m, 3H), 6.92 (d, J= 3.6 Hz, 1H); 13C{H} NMR (150 MHz, CDCl3) δ 163.5 (d, J=
246.6 Hz), 145.3, 141.7, 129.6 (d; J= 68.7 Hz), 128.9, 125.1, 123.8, 117.4, 115.4
(d, J= 17.7 Hz), 113.0, 91.3.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
4-(3-bromoimidazo[1,2-a]pyridin-2-yl)benzonitrile (4d): 27c
0
(Eluent: 5% EtOAc/hexane); 71% yield (52.8 mg);white solid, Mp: 175 C;
1H NMR (600 MHz, CDCl3) δ 8.27 (d, J= 7.8 Hz, 2H), 8.18 (d, J= 7.2 Hz, 1H),
7.74 (d, J= 7.8 Hz, 2H), 7.64 (d, J= 9.0 Hz, 1H), 7.31 (t, J= 7.8 Hz, 1H), 6.98
13
(t, J= 6.6 Hz, 1H); C{H} NMR (150 MHz, CDCl3) δ 145.6, 140.4, 137.3,
132.2, 128.0, 125.8, 124.0, 118.8, 117.8, 113.6, 111.4, 92.8.
3-bromo-2-(4-ethylphenyl)-6-methylimidazo[1,2-a]pyridine (4e):
(Eluent: 5% EtOAc/hexane); 82% yield (64.5 mg); white solid, Mp: 120 0C;
1H NMR (600 MHz, CDCl3) δ 8.03 (d, J = 8.0 Hz, 2H), 7.87 (s, 1H), 7.49 (d,
J = 9.1 Hz, 1H), 7.29 (d, J = 8.0 Hz, 2H), 7.03 (d, J = 9.2 Hz, 1H), 2.68 (q, J
13
= 7.5 Hz, 2H), 2.32 (s, 3H), 1.29 – 1.24 (m, 3H); C{H} NMR (150 MHz,
CDCl3 ) δ 144.32, 144.19, 142.34, 130.31, 127.96, 127.83, 127.62, 122.61,
121.46, 116.68, 90.79, 77.00, 28.60, 18.22, 15.35. HRMS-ESI (m/z) [M+Na]+calcd. For
C16H15BrN2Na: 337.0316; Found: 337.0308.
3-bromo-2-(4-methoxyphenyl)-6-methylimidazo[1,2-a]pyridine (4f): 28b
(Eluent: 15% EtOAc/hexane); 78% yield (61.8 mg); yellow solid, Mp: 135
0C; 1H NMR (600 MHz, CDCl3) δ 8.04 (d, J = 8.3 Hz, 2H), 7.87 (s, 1H), 7.48
(d, J = 9.1 Hz, 1H), 7.03 (d, J = 8.4 Hz, 1H), 6.98 (d, J = 8.9 Hz, 2H), 3.82
13
(s, 3H), 2.32 (s, 3H); C{H} NMR (150 MHz, CDCl3 ) δ 159.51, 144.31,
142.16, 128.97, 128.58, 127.97, 125.53, 122.59, 121.46, 116.57, 113.77,
90.35, 77.00, 55.20, 18.24.
3-bromo-2-(4-chlorophenyl)-5-methyl-3aH-indene (4g):
ACS Paragon Plus Environment

Page 21 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
(Eluent: 15% EtOAc/hexane); 62% yield (49.7 mg); yellow solid, Mp: 120 0C;
1H NMR (600 MHz, CDCl3) δ 8.04 (d, J= 1.8 Hz, 2H), 7.87 (s, 1H), 7.48 (d, J
= 9.0 Hz, 1H), 7.40 (d, J = 2.7 Hz, 2H), 7.07 (d, J = 1.2 Hz, 1H), 2.34 (s, 3H);
13C{H} NMR (150 MHz, CDCl3) δ 144.4, 141.1, 133.9, 131.5, 128.89, 128.5,
128.4, 123.0, 121.5, 116.8, 91.2, 18.3. HRMS-ESI (m/z) [M+Na]+calcd. For
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
C14H10BrClN2Na: 342.9614; Found: 342.9596.
.4-(3-bromo-6-methylimidazo[1,2-a]pyridin-2-yl)benzonitrile (4h):
(Eluent: 15% EtOAc/hexane); 96% yield (74.8 mg); yellow solid, Mp: 190 0C;
1H NMR (600 MHz, CDCl3 ) δ 8.24 (d, J = 8.4 Hz, 2H), 7.93 (s, 1H), 7.70 (d, J
= 8.7 Hz, 2H), 7.51 (d, J = 9.2 Hz, 1H), 7.13 (dd, J = 9.2, 1.2 Hz, 1H), 2.39 (s,
3H); 13C{H} NMR (150 MHz, CDCl3 ) δ 144.70, 140.11, 137.55, 132.14,
129.04, 127.91, 123.55, 121.66, 118.92, 117.15, 111.27, 92.40, 77.00, 18.35.
HRMS-ESI (m/z) [M+H]+calcd. For C15H11BrN3: 312.0136; Found: 312.012.
4-(3-bromo-8-methylimidazo[1,2-a]pyridin-2-yl)benzonitrile (4i): 20
(Eluent: 15% EtOAc/hexane); 87% yield (67.8 mg);white solid, Mp: 185 0C; 1H
NMR (600 MHz, CDCl3) δ 8.28 (d, J= 8.4 Hz, 2H), 8.04 (d, J= 7.2 Hz, 1H), 7.73
(d, J= 8.4 Hz, 2H), 7.08 (d, J= 7.2 Hz, 1H), 6.88 (t, J= 7.2 Hz, 1H), 2.64 (s, 3H);
13C{H} NMR (150 MHz, CDCl3) δ 145.9, 139.8, 137.6, 132.1, 128.1, 127.9,
124.4, 120.8, 118.9, 113.5, 111.2, 93.1, 16.4.
3-bromo-2-(4-chlorophenyl)-7-methoxyimidazo[1,2-a]pyridine (4j):
(Eluent: 15% EtOAc/hexane); 80% yield (67.4 mg); white solid, Mp: 158 0C; 1H
NMR (600 MHz, CDCl3) δ 8.04 (d, J= 8.4 Hz, 2H), 7.93 (d, J= 7.2 Hz, 1H), 7.41
(d, J= 9.0 Hz, 2H), 6.86 (d, J= 1.8 Hz, 1H), 6.62-6.60 (m, 1H), 3.85 (s, 3H);
13C{H} NMR (150 MHz, CDCl3) δ 158.3, 146.6, 133.8, 131.4, 124.2, 108.2, 94.7,
93.8, 89.8, 55.6. HRMS-ESI (m/z) [M+H]+calcd. For C14H11BrClN2O: 336.9743;
Found: 336.9743.
3-bromo-7-chloro-2-phenylimidazo[1,2-a]pyridine (4k):
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 22 of 34
1
2
3
4
5
6
7
0
(Eluent: 15% EtOAc/hexane); 64% yield (49.1 mg); yellow solid, Mp: 169 C ;
1H NMR (600 MHz, CDCl3) δ 8.10-8.06 (m,3H), 7.63 (s, 1H), 7.49 (t, J= 8.4 Hz,
13
2H), 7.41 (t, J= 7.8 Hz, 1H), 6.90 (t, J= 6.6 Hz, 1H); C{H} NMR (150 MHz,
8
9
CDCl3) δ 145.0, 144.3, 143.5, 133.0, 132.4, 131.6,128.5, 128.4, 127.7, 124.2,
116.3, 115.7, 114.6, 91.9. HRMS-ESI (m/z) [M+H]+calcd. For C13H9BrClN2:
306.9638; Found: 306.9618.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
3,6-dibromo-2-phenylimidazo[1,2-a]pyridine (4l):
(Eluent: 5% EtOAc/hexane); 77% yield (67.76 mg);white solid, Mp: 155 0C ; 1H
NMR (600 MHz, CDCl3) δ 8.29 (s, 1H), 8.14 (d, J= 7.8 Hz, 2H), 7.51 (d, J= 9.0
Hz, 1H), 7.48 (t, J= 7.8 Hz, 2H), 7.40 (t, J= 6.6 Hz, 1H), 7.29 (dd, J= 9.0 Hz, 1H);
13C{H} NMR (150 MHz, CDCl3) δ 143.8, 143.4, 132.3, 128.5, 128.4, 127.7,
124.0, 118.1, 107.8, 91.9. HRMS-ESI (m/z) [M+H]+calcd. For C13H9Br2N2: 350.9132; Found:
350.9132.
3-bromo-6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridine (4m):
0
(Eluent: 5%EtOAc/hexane); 63% yield (53.86 mg); white solid, Mp: 160 C;
1H NMR (600 MHz, CDCl3), δ 8.17 (s, 1H), 8.03 (d, J = 8.4 Hz, 2H), 7.54 (d, J
= 9.0 Hz, 1H), 7.42 (d, J = 8.4 Hz, 2H), 7.21 (d, J = 8.4 Hz, 1H); 13C{H} NMR
(150 MHz, CDCl3) δ 143.7, 142.4, 134.4, 130.8, 128.9, 128.7, 127.6, 121.9,
121.7, 117.9, 92.1; HRMS-ESI (m/z) [M+H]+calcd. For C13H8BrCl2N2:
340.9248; Found: 340.9233.
3-bromo-6-fluoro-2-(p-tolyl)imidazo[1,2-a]pyridine (4n):
(Eluent: 15% EtOAc/hexane); 52% yield (39.6 mg); yellow solid, Mp:155 0C ;
1H NMR (600 MHz, CDCl3) δ 8.12 (d, J = 2.7 Hz, 1H), 7.99 (d, J = 8.4 Hz, 2H),
7.61 (dd, J = 9.6, 4.9 Hz, 1H), 7.29 (d, J = 8.0 Hz, 2H), 7.19 – 7.11 (m, 1H),
2.41 (s, 3H); 13C{H} NMR (150 MHz, CDCl3) δ 154.55, 152.97, 144.19,
143.00, 138.42, 129.7, 129.23, 127.64, 118.07 (d, J = 8.8 Hz), 117.04, 116.88,
111.06, 110.78, 92.65, 21.33. HRMS-ESI (m/z) [M+H]+calcd. For C14H11BrFN2: 305.0090;
Found: 305.008.
ACS Paragon Plus Environment

Page 23 of 34
The Journal of Organic Chemistry
1
2
3
4
3,6-dibromo-2-(4-ethylphenyl)imidazo[1,2-a]pyridine (4o):
5
6
(Eluent: 15% (EtOAc/hexane); 80% yield (76.0 mg); yellow solid, Mp: 130
7
8
9
0C; 1H NMR (600 MHz, CDCl3 ) δ 8.31 (s, 1H), 8.03 (d, J = 8.0 Hz, 2H), 7.52
(d, J = 9.5 Hz, 1H), 7.31 (dd, J = 12.0, 4.9 Hz, 3H), 2.71 (q, J = 7.4 Hz, 2H),
1.29 (t, J = 7.5 Hz, 3H); 13C{H} NMR (150 MHz, CDCl3) δ 144.85, 143.87,
143.65, 129.76, 128.43, 128.06, 127.80, 124.08, 118.13, 107.79, 91.66, 77.00,
28.71, 15.41. HRMS-ESI (m/z) [M+H]+calcd. For C15H13Br2N2: 378.9445. Found: 378.944.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
23
3-bromoimidazo[1,2-a]pyridine (4p):
0
1
(Eluent: 30% EtOAc/hexane); 38% yield (37.0 mg); Brown solid, Mp: 90 C; H
NMR (600 MHz, CDCl3) δ 8.11 (t, J = 6.1 Hz, 1H), 7.69 (s, 1H), 7.59 (d, J = 9.0 Hz,
1H), 7.21 (t, J = 7.7 Hz, 1H), 6.91 (t, J = 6.5 Hz, 1H). 13C{H} NMR (150 MHz, CDCl3)
δ 147.71, 140.21, 125.96, 124.82, 117.83, 113.20, 60.72 .
3-chloro-2-phenylimidazo[1,2-a]pyridine (5a):25b
0
(Eluent: 15% (EtOAc/hexane); 65% yield (37.05 mg) yellow solid, Mp: 115 C;
1H NMR (600 MHz, CDCl3) δ 8.15 (t, J = 7.4 Hz, 2H), 8.10 (d, J = 6.8 Hz, 1H),
7.64 (d, J = 9.1 Hz, 1H), 7.49 (t, J = 7.9 Hz, 2H), 7.38 (t, J = 7.4 Hz, 1H), 7.25 –
7.22 (m, 1H), 6.92 (t, J = 6.8 Hz, 1H); 13C{H} NMR (150 MHz, CDCl3 ) δ 143.68,
139.75, 132.48, 128.51, 128.21, 127.45, 124.82, 122.65, 117.62, 112.87, 105.66,
77.00.
4-(3-chloro-8-methylimidazo[1,2-a]pyridin-2-yl)benzonitrile (5b):
(Eluent: 15% EtOAc/hexane); 46% yield (30.7 mg); yellow solid, Mp: 190 0C;
1H NMR (600 MHz, CDCl3) δ 8.29 (d, J = 8.0 Hz, 2H), 7.99 (d, J = 6.8 Hz, 1H),
7.74 (d, J = 8.1 Hz, 2H), 7.08 (d, J = 6.8 Hz, 1H), 6.88 (t, J = 6.8 Hz, 1H), 2.65
13
(s, 3H); C{H} NMR (150 MHz, CDCl3 ) δ 144.34, 137.37, 137.12, 132.28,
128.09, 127.76, 124.23, 120.62, 119.03, 113.50, 111.19, 77.00, 16.43. HRMS-
ESI (m/z) [M+H]+calcd. For C15H11ClN3: 268.0642; Found: 268.0613.
5-iodo-6-phenylimidazo[2,1-b]thiazole (7a): 26a
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 24 of 34
1
2
3
4
5
6
(Eluent: 15% EtOAc/hexane); 71% yield (57.8 mg); yellow solid, Mp: 130
0C; 1H NMR (600 MHz, CDCl3) δ 7.99 (d, J = 7.6 Hz, 2H), 7.45 (dd, J =
10.8, 6.1 Hz, 3H), 7.35 (t, J = 7.2 Hz, 1H), 6.92 (d, J = 4.3 Hz, 1H); 13C{H}
7
8
9
NMR (150 MHz, CDCl3) δ 150.82, 149.41, 133.61, 128.33, 127.88, 127.45, 119.22, 112.18.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
5-iodo-6-(p-tolyl)imidazo[2,1-b]thiazole (7b): 26a
(Eluent: 15% EtOAc/hexane); 34% yield (28.9 mg); white solid, Mp: 135
0C; 1H NMR (600 MHz, CDCl3) δ 7.87 (d, J = 8.0 Hz, 2H), 7.43 (d, J = 4.6
Hz, 1H), 7.26 (d, J = 2.1 Hz, 2H), 6.91 (d, J = 4.5 Hz, 1H), 2.40 (s, 3H);
13C{H} NMR (150 MHz, CDCl3) δ 149.56, 137.72, 131.14, 129.05, 127.36, 119.21, 112.42,
111.98, 77.00, 53.72, 21.30.
6-(4-ethylphenyl)-5-iodoimidazo[2,1-b]thiazole (7c):
(Eluent: 15% EtOAc/hexane); 63% yield (55.7 mg); yellow solid, Mp:
145 0C;1H NMR (600 MHz, CDCl3) δ 7.91 (d, J = 8.2 Hz, 2H), 7.42 (d,
J = 4.5 Hz, 1H), 7.28 (d, J = 8.0 Hz, 2H), 6.89 (d, J = 4.5 Hz, 1H), 2.70
(d, J = 7.5 Hz, 2H), 1.28 (t, J = 7.6 Hz, 3H); 13C{H} NMR (150 MHz, CDCl3) δ 150.69, 149.51,
144.01, 130.99, 127.83, 127.39, 119.20, 111.95, 77.00, 53.70, 28.65, 15.41. HRMS-ESI (m/z)
[M+H]+calcd. For C13H12IN2S: 354.9766; Found: 354.9772.
6-(4-fluorophenyl)-5-iodoimidazo[2,1-b]thiazole (7d): 28c
(Eluent: 15% EtOAc/hexane); 45% yield (38.7 mg); yellow solid, Mp:
145 0C; 1H NMR (600 MHz, CDCl3 ) δ 7.98 – 7.90 (m, 2H), 7.42 (d, J =
4.6 Hz, 1H), 7.15 – 7.09 (m, 2H), 6.92 (d, J = 4.5 Hz, 1H); 13C{H} NMR
(150 MHz, CDCl3) δ 163.34, 150.87, 148.66, 129.78, 129.25 (d, J = 7.7 Hz), 119.21, 115.36,
115.21, 112.26, 53.91.
6-(4-chlorophenyl)-5-iodoimidazo[2,1-b]thiazole (7e):
(Eluent: 15% EtOAc/hexane); 40% yield (36.0 mg); yellow solid, Mp:
0
1
150 C; H NMR (600 MHz, CDCl3) δ 7.94 (d, J= 9.0 Hz, 2H), 7.42-
7.39. (m, 3H), 6.92 (d, J= 4.2 Hz, 1H); 13C{H} NMR (150 MHz,
ACS Paragon Plus Environment

Page 25 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
CDCl3) δ 150.9, 148.2, 133.7, 132.1, 128.6, 128.5, 119.1, 112.4, 54.2. HRMS-ESI (m/z)
[M+H]+calcd. For C11H7ClIN2S: 360.9063; Found: 360.9053.
7
8
2-(4-ethylphenyl)-3-iodobenzo[d]imidazo[2,1-b]thiazole (7f):
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(Eluent: 15% EtOAc/hexane); 55% yield (55.5 mg); yellow solid, Mp:
180 0C; 1H NMR (600 MHz, CDCl3 ) δ 8.68 (d, J = 8.3 Hz, 1H), 7.89
(d, J = 8.2 Hz, 2H), 7.70 (d, J = 7.9 Hz, 1H), 7.47 (t, J = 7.4 Hz, 1H),
7.39 (t, J = 7.6 Hz, 1H), 7.30 (d, J = 8.0 Hz, 2H), 2.71 (q, J = 7.6 Hz,
2H), 1.29 (t, J = 7.9 Hz, 3H); 13C{H} NMR (150 MHz, CDCl3 ) δ 150.94, 150.42, 144.17, 133.76,
132.44, 130.80, 130.54, 130.48, 129.70, 128.01, 127.78, 126.86, 125.38, 125.15, 124.24, 113.83,
77.00, 53.85, 28.68, 15.42. HRMS-ESI (m/z) [M+H]+calcd. For C17H14IN2S: 404.9922. Found:
404.9916.
3-iodo-2-(2-methoxyphenyl)benzo[d]imidazo[2,1-b]thiazole (7g):
(Eluent: 5% EtOAc/hexane); 50% yield (50.7 mg);white solid, Mp: 145
0C; 1H NMR (600 MHz, CDCl3 ) δ 8.71 (d, J = 8.3 Hz, 1H), 7.72 (d, J =
7.9 Hz, 1H), 7.57 (d, J = 7.2 Hz, 1H), 7.50 (dt, J = 16.1, 5.3 Hz, 2H), 7.40
(dt, J = 24.3, 7.8 Hz, 2H), 6.93 (dd, J = 8.2, 2.4 Hz, 1H), 3.89 (s, 3H);
13C{H} NMR (150 MHz, CDCl3) δ 129.31, 126.56, 125.47, 125.32, 124.83, 124.31, 123.70,
120.57, 114.33, 113.97, 113.13, 77.00, 55.38. HRMS-ESI (m/z) [M+H]+calcd. For C16H12IN2OS:
406.9715. Found: 406.969.
2-(4-chlorophenyl)-3-iodobenzo[d]imidazo[2,1-b]thiazole (7h): 21a
(Eluent: 15% EtOAc/hexane); 63% yield (64.5 mg); white solid, Mp:
130 0C; 1H NMR (600 MHz, CDCl3) δ 8.69 (d, J = 8.3 Hz, 1H), 7.94 –
7.89 (m, 2H), 7.72 (d, J = 7.9 Hz, 1H), 7.52 – 7.45 (m, 1H), 7.45 – 7.39
13
(m, 3H); C{H} NMR (150 MHz, CDCl3) δ 133.93, 133.90, 133.67,
133.65, 131.97, 130.53, 129.32, 128.52, 125.53, 125.43, 124.35, 113.91, 77.00.
5-bromo-6-phenylimidazo[2,1-b]thiazole (8a): 21c
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 26 of 34
1
2
3
4
5
6
7
(Eluent: 15% EtOAc/hexane); 89% yield (62.0 mg); white solid, Mp: 100 0C;
1H NMR (600 MHz, CDCl3) δ 7.99 (t, J = 19.4 Hz, 2H), 7.41 (d, J = 22.6 Hz,
3H), 7.33 (s, 1H), 6.89 (s, 1H). 13C{H} NMR (150 MHz, CDCl3 ) δ 148.75,
8
9
143.92, 133.04, 128.41, 127.75, 126.88, 117.49, 112.92, 90.07.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
5-bromo-6-(p-tolyl)imidazo[2,1-b]thiazole (8b):
(Eluent: 15% EtOAc/hexane); 77% yield (56.4 mg); yellow solid, Mp:
0
122 C; 1H NMR (600 MHz, CDCl3 ) δ 7.90 (d, J = 8.1 Hz, 2H), 7.35
(d, J = 4.6 Hz, 1H), 7.24 (d, J = 8.1 Hz, 2H), 6.84 (d, J = 4.6 Hz, 1H),
2.38 (s, 3H); 13C{H} NMR (150 MHz, CDCl3) δ 148.56, 143.90, 137.53, 130.12, 129.08, 126.72,
117.42, 112.71, 89.64, 77.00, 21.23. HRMS-ESI (m/z) [M+H]+calcd. For C12H10BrN2S: 292.9748;
Found: 292.975.
5-bromo-6-(4-ethylphenyl)imidazo[2,1-b]thiazole (8c):
(Eluent: 15% EtOAc/hexane); 85% yield (65.2 mg); white solid, Mp: 167
0C ; 1H NMR (600 MHz, CDCl3) δ 7.92 (d, J = 8.0 Hz, 2H), 7.38 (d, J =
4.6 Hz, 1H), 7.27 (d, J = 8.1 Hz, 2H), 6.87 (d, J = 4.4 Hz, 1H), 2.68 (d, J = 7.8 Hz, 2H), 1.26 (t, J
= 7.7 Hz, 3H);13C{H} NMR (150 MHz, CDCl3) δ 148.62, 144.05, 143.91, 130.44, 127.92, 126.84,
117.48, 112.70, 89.67, 77.00, 28.65, 15.42. HRMS-ESI (m/z) [M+H]+calcd. For C13H12BrN2S:
306.9905; Found: 306.9900.
5-bromo-6-(4-fluorophenyl)imidazo[2,1-b]thiazole (8d): 21b
(Eluent: 15% EtOAc/hexane); 83% yield (61.6 mg); yellow solid, Mp: 145
0C; 1H NMR (600 MHz, CDCl3) δ 7.97 (dd, J = 8.2, 5.4 Hz, 2H), 7.39 (d,
J = 4.3 Hz, 1H), 7.11 (t, J = 8.5 Hz, 2H), 6.90 (d, J = 4.4 Hz, 1H); 13C{H} NMR (150 MHz,
CDCl3); δ 163.21, 161.57, 148.78, 143.13, 128.65 (d, J = 8.3 Hz), 117.49, 115.43, 115.29, 112.99.
5-bromo-6-(4-chlorophenyl)imidazo[2,1-b]thiazole (8e):
(Eluent: 15% EtOAc/hexane); 65% yield (50.8 mg); yellow solid, Mp:
156 0C;1H NMR (600 MHz, CDCl3) δ 7.95 (d, J = 8.9 Hz, 2H), 7.43 –
7.36 (m, 3H), 6.92 (d, J = 4.6 Hz, 1H); 13C{H} NMR (150 MHz, CDCl3
ACS Paragon Plus Environment

Page 27 of 34
The Journal of Organic Chemistry
1
2
3
4
5
6
) δ 148.91, 142.89, 134.39, 133.57, 132.57, 131.57, 128.63, 128.08, 117.49, 113.19, 90.21, 77.00.
HRMS-ESI (m/z) [M+H]+calcd. For C11H7ClBrN2S: 312.9202; Found: 312.919.
3-bromo-2-(4-ethylphenyl)benzo[d]imidazo[2,1-b]thiazole (8f):
7
8
9
(Eluent: 15% EtOAc/hexane); 77% yield (68.7 mg); yellow solid, Mp:
0
1
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
110 C; H NMR (600 MHz, CDCl3) δ 8.42 (d, J = 8.2 Hz, 1H), 7.95
(d, J = 8.0 Hz, 2H), 7.69 (d, J = 8.0 Hz, 1H), 7.45 (t, J = 7.8 Hz, 1H),
7.36 (t, J = 7.8 Hz, 1H), 7.30 (d, J = 8.1 Hz, 2H), 2.70 (q, J = 7.6 Hz,
2H), 1.28 (t, J = 7.5 Hz, 3H); 13C{H} NMR (150 MHz, CDCl3 ) δ 147.93, 144.44, 144.04, 133.10,
130.20, 130.14, 127.90, 127.15, 125.80, 125.07, 124.16, 113.60, 91.43, 77.00, 28.67, 15.44.
HRMS-ESI (m/z) [M+H]+calcd. For C17H14BrN2S: 357.0061. Found: 357.0056.
3-bromo-2-(2-methoxyphenyl)benzo[d]imidazo[2,1-b]thiazole (8g):
(Eluent: 15% EtOAc/hexane); 56% yield (50.2 mg); white solid, Mp: 135
0C; 1H NMR (600 MHz, CDCl3 ) δ 8.44 (d, J = 8.2 Hz, 1H), 7.70 (d, J =
8.0 Hz, 1H), 7.64 (d, J = 7.9 Hz, 1H), 7.60 – 7.58 (m, 1H), 7.46 (t, J = 7.4
Hz, 1H), 7.40 – 7.35 (m, 2H), 6.92 (dd, J = 8.2, 2.5 Hz, 1H), 3.89 (s, 3H); 13C{H} NMR (150
MHz, CDCl3 ) δ 159.65, 148.02, 144.14, 134.11, 133.08, 130.20, 129.40, 125.86, 125.21, 124.20,
119.65, 114.07, 113.71, 112.31, 92.03, 77.00, 55.34. HRMS-ESI (m/z) [M+H]+calcd. For
C16H12BrN2OS: 358.9854. Found: 358.983.
3-bromo-2-(4-chlorophenyl)benzo[d]imidazo[2,1-b]thiazole (8h):
(Eluent: 5% EtOAc/hexane); 81% yield (73.5 mg); yellow solid, Mp:
0
1
178 C; H NMR (600 MHz, CDCl3) δ 8.41 (dd, J = 8.3, 0.5 Hz, 1H),
8.01 – 7.92 (m, 2H), 7.69 (dd, J = 8.0, 0.8 Hz, 1H), 7.45 (dd, J = 8.3, 1.1
13
Hz, 1H), 7.43 – 7.35 (m, 3H); C{H} NMR (150 MHz, CDCl3) δ
148.22, 143.19, 133.65, 132.96, 131.31, 130.16, 125.92, 125.31, 124.22,
113.66, 91.94, 77.00, 29.68. HRMS-ESI (m/z) [M+H]+calcd. For C15H9BrClN2S: 362.9358.
Found: 362.9355.
5-chloro-6-phenylimidazo[2,1-b]thiazole (9a): 21c
ACS Paragon Plus Environment

The Journal of Organic Chemistry
Page 28 of 34
1
2
3
4
5
6
7
8
9
(Eluent: 5% EtOAc/hexane); 48% yield (28.08 mg); yellow solid, Mp:105 0C; 1H NMR (600 MHz,
CDCl3) δ 8.00 (d, J = 7.5 Hz, 2H), 7.45 (t, J = 7.8 Hz, 2H), 7.40 (d, J = 4.5 Hz,
1H), 7.33 (t, J = 7.3 Hz, 1H), 6.91 (d, J = 4.5 Hz, 1H); 13C{H} NMR (150
MHz, CDCl3) δ 147.31, 141.32, 140.92, 132.61, 128.51, 127.73, 126.56,
116.65, 113.34, 77.00.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
2-(4-bromophenyl)-3-chlorobenzo[d]imidazo[2,1-b]thiazole (9b):
(Eluent: 5% EtOAc/hexane); 42% yield (38.11 mg); yellow solid, Mp:
170 0C; 1H NMR (600 MHz, CDCl3 ) δ 8.23 (d, J = 8.2 Hz, 1H), 7.96 –
7.85 (m, 2H), 7.70 (d, J = 8.0 Hz, 1H), 7.62 – 7.52 (m, 2H), 7.46 (t, J =
8.0 Hz, 1H), 7.38 (t, J = 7.9 Hz, 1H); 13C{H} NMR (150 MHz, CDCl3)
δ 140.27, 132.56, 131.71, 131.55, 130.14, 128.22, 126.26, 125.40, 124.33, 121.83, 113.58, 77.00.
HRMS-ESI (m/z) [M+H]+calcd. For C15H9BrClN2S: 362.9358. Found: 362.9350.
3-chloro-2-(4-ethylphenyl)benzo[d]imidazo[2,1-b]thiazole (9c):
0
1
(Eluent: 5% EtOAc/hexane); 40% yield (31.20 mg); yellow solid, Mp: 170 C, H NMR (600
MHz, CDCl3) δ 8.26 (d, J = 8.2 Hz, 1H), 7.95 (d, J = 8.2 Hz, 2H),
7.71 (d, J = 8.0 Hz, 1H), 7.47 (t, J = 7.7 Hz, 1H), 7.38 (t, J = 7.6 Hz,
1H), 7.30 (d, J = 8.0 Hz, 2H), 2.70 (q, J = 7.6 Hz, 2H), 1.28 (t, J =
7.8 Hz, 3H); 13C{H} NMR (150 MHz, CDCl3) δ 143.97, 137.78,
128.02, 127.10, 126.67, 126.07, 125.11, 125.07, 124.58, 124.19, 122.22, 113.46, 77.00, 28.69,
15.47. HRMS-ESI (m/z) [M+H]+calcd. For C17H14ClN2S: 313.0566. Found: 313.0531.
1-(3-bromo-1H-indol-1-yl)-2,2-dimethylpropan-1-one (9g):
99% yield (279.0 mg); yellow liquid; 1H NMR (600 MHz, CDCl3) δ 8.53 (d, J =
8.4 Hz, 1H), 7.81 (s, 1H), 7.54 (d, J = 7.7 Hz, 1H), 7.42 (t, J = 7.7 Hz, 1H), 7.37 (t,
J = 7.5 Hz, 1H), 1.53 (s, 9H). 13C{H} NMR (150 MHz, CDCl3) δ 176.29, 135.99,
128.27, 126.25, 124.38, 124.05, 119.04, 117.26, 99.25, 41.18, 28.55.HRMS-ESI
(m/z) [M+H]+calcd. For C13H15BrNO: 280.0322. Found: 280.0349.
3-bromoisoquinoline 9h 22
(Eluent: 20% EtOAc/hexane); 40% yield (82.40 mg); Yellow liquid; 1H NMR (600
MHz, CDCl3) δ 9.14 (s, 1H), 8.70 (s, 1H), 8.13 (d, J = 8.4 Hz, 1H), 7.95 (dd, J =
ACS Paragon Plus Environment

Page 29 of 34
The Journal of Organic Chemistry
1
2
3
4
8.0, 3.3 Hz, 1H), 7.79 (t, J = 7.3 Hz, 1H), 7.65 (t, J = 7.4 Hz, 1H). 13C{H} NMR (150 MHz, CDCl3)
5
6
δ 151.66, 144.57, 134.66, 131.61, 129.65, 128.17, 127.78, 125.82, 119.59.
7
8
5-iodopyridin-2-amine (11a): 26b
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(Eluent: 5% EtOAc/hexane); 47% yield (25.8 mg); off white solid, Mp: 125
0C; 1H NMR (600 MHz, CDCl3) δ 8.20 (s, 1H), 7.60 (d, J = 8.1 Hz, 1H), 6.41
– 6.22 (m, 1H), 4.53 (s, 2H); 13C{H} NMR (150 MHz, CDCl3) δ 157.26,
153.74, 145.29, 110.83, 77.82, 77.00.
5-bromopyridin-2-amine (11b): 19
(Eluent: 5% EtOAc/hexane); 58% yield (25.0 mg); white solid, Mp: 135 0C; 1H
NMR (600 MHz, CDCl3) δ 8.06 (d, J = 2.1 Hz, 1H), 7.46 (dd, J = 9.1, 2.3 Hz,
1H), 6.38 (d, J = 8.9 Hz, 1H), 4.51 (s, 2H); 13C{H} NMR (150 MHz, CDCl3, ) δ
157.01, 148.65, 140.08, 110.01, 108.23, 77.00.
5-chloro-4,6-dimethylpyrimidin-2-amine 11c 15
0
(Eluent: 20% EtOAc/hexane); 51% yield (80 mg); White solid, Mp: 180 C;
1H NMR (600 MHz,) δ 6.61 (s, 1H), 2.29 (s, 3H). 13C{H} NMR (150 MHz, ) δ
164.00, 161.35, 116.54, 22.42.
2,3-diphenylimidazo[1,2-a]pyridine 12a 25a
(Eluent: 15% EtOAc/hexane); 60%(16.2 mg)(from 3a), 65%(17.55 mg)(from
4a), yield (16.2 mg); White solid, Mp: 148 0C; 1H NMR (600 MHz,) δ 1H NMR
(600 MHz, ) δ 7.96 (d, J = 6.9 Hz, 2H), 7.72 – 7.64 (m, 6H), 7.52 (d, J = 7.0 Hz,
4H), 7.49 (d, J = 7.7 Hz, 2H), 7.46 (d, J = 7.2 Hz, 4H), 7.27 (dt, J = 10.2, 7.2
Hz, 7H), 7.22 – 7.17 (m, 2H), 6.74 (s, 2H).13C{H} NMR (150 MHz, ) δ 144.78
(s), 142.36 (s), 134.09 (s), 130.71 (s), 129.83 (s), 129.52 (s), 128.86 (s), 128.24 (s), 128.08 (s),
127.45 (s), 124.68 (s), 123.26 (s), 117.51 (s), 112.27 (s).
ASSOCIATED CONTENT
Supporting Information:
ACS Paragon Plus Environment